Filing Details
- Accession Number:
- 0001213900-23-041179
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-18 16:15:14
- Reporting Period:
- 2023-05-17
- Accepted Time:
- 2023-05-18 16:15:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1514183 | Silo Pharma Inc. | SILO | Apparel & Other Finishd Prods Of Fabrics & Similar Matl (2300) | 462137136 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1569077 | Eric Weisblum | C/O Silo Pharma, Inc. 560 Sylvan Ave., Suite 3160 Englewood Cliffs NJ 07632 | Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-05-17 | 2,500 | $2.06 | 157,224 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2023-05-18 | 500 | $2.11 | 157,724 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.000 to $2.0899. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at $2.104 and $2.109. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.